Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Glucocorticoid impairs angiogenesis-dependent osteogenesis by downregulating EphB4 in endothelial cells
Qinghua Ren1, Xing Rong1, Ting Liu1
1Department of Bone Metabolism, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan, China; Center of Osteoporosis and Bone Mineral Research, Shandong University, Jinan, China.
Abstract:
Long-term or high-dose glucocorticoids (GCs) exposure leads to rapid bone loss and microarchitectural deterioration, ultimately resulting in glucocorticoid-induced osteoporosis (GIOP). Although the progression of GIOP is closely associated with impaired type H blood vessel function, the underlying mechanisms remain insufficiently defined. Using a dexamethasone (DEX)-induced GIOP mouse model, we observed a simultaneous reduction in type H blood vessels and Ephrin type-B receptor 4 (EphB4) expression. Co-culture of bone marrow mesenchymal stem cells (BMSCs) with endothelial cells (ECs) overexpressing EphB4 confirmed that endothelial EphB4 is a critical regulator of angiogenesis-dependent osteogenesis, a process disrupted by DEX-mediated EphB4 downregulation. Specifically, DEX-induced EphB4 downregulation induced cellular senescence in ECs, and the resulting senescence-associated secretory phenotype (SASP) may further impair BMSC osteogenic differentiation. We additionally observed that diminished EphB4-EphrinB2 crosstalk between ECs and BMSCs may further exacerbate osteogenesis. The Wnt/β-catenin pathway was identified as a critical mediator through which DEX inhibits EphB4 expression in ECs. Collectively, these findings reveal a previously unrecognized EphB4-mediated mechanism contributing to GIOP pathogenesis and provide mechanistic insight into potential therapeutic strategies targeting angiogenesis-osteogenesis coupling.
Insights
Glucocorticoid-induced osteoporosis (GIOP) involves impaired blood vessel function. This study reveals that dexamethasone downregulates Ephrin type-B receptor 4 (EphB4), disrupting blood vessel formation and bone health.
Area of Science:
- Endocrinology
- Vascular Biology
- Bone Biology
Background:
- Glucocorticoids (GCs) cause osteoporosis by impairing bone microarchitecture and blood vessel function.
- The specific mechanisms linking impaired type H blood vessel function to glucocorticoid-induced osteoporosis (GIOP) are not fully understood.
Purpose of the Study:
- To investigate the role of Ephrin type-B receptor 4 (EphB4) in dexamethasone (DEX)-induced osteoporosis.
- To elucidate the mechanisms by which DEX affects angiogenesis-osteogenesis coupling.
Main Methods:
- Utilized a dexamethasone (DEX)-induced GIOP mouse model.
- Performed co-culture experiments with bone marrow mesenchymal stem cells (BMSCs) and endothelial cells (ECs) overexpressing EphB4.
- Investigated the Wnt/β-catenin pathway's role in DEX-mediated EphB4 downregulation.
Main Results:
- DEX treatment reduced type H blood vessels and EphB4 expression in the GIOP mouse model.
- Endothelial EphB4 is crucial for angiogenesis-dependent osteogenesis, and DEX downregulates it.
- DEX-induced EphB4 downregulation promoted endothelial cell senescence and impaired BMSC osteogenic differentiation.
- Reduced EphB4-EphrinB2 crosstalk and Wnt/β-catenin pathway activation were implicated in DEX's effects.
Conclusions:
- EphB4 plays a critical role in regulating angiogenesis-osteogenesis coupling, and its downregulation by DEX contributes to GIOP.
- DEX-induced endothelial cell senescence and impaired BMSC differentiation are key mechanisms in GIOP pathogenesis.
- Targeting the EphB4 pathway offers a potential therapeutic strategy for GIOP.
More Related Videos
13:16Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts
Published on: December 22, 2015
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
TGF - β Signaling Pathway
Cell Specific Gene Expression
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...